Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
We recently compiled a list of the Best Future Stocks For The Long-Term. In this article, we will look at where Pfizer Inc.
The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the ...
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
Jackson County Health Department (JCHD) is now providing flu vaccinations by appointment. An annual flu vaccination is ...
In Depth
Mayo Clinic on MSN10hIn Depth
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...
Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation. Access to and awareness of vaccines is more important than ever, especially in a globally ...
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.
Cheryl Hines is reportedly fuming over her husband Robert F Kennedy Jr's alleged sexting scandal with reporter Olivia Nuzzi, which began during his presidential campaign. New York Magazine placed ...
September 21, 2024 • Neighbors in Greensboro say Ryan Routh, the man accused of pointing a rifle at the golf course where Donald Trump was playing, wasn't someone they knew well. But he was well ...